Bromodomain-containing protein 9 (BRD9), a component of SWItch/Sucrose Non-Fermentable (SWI/SNF) remodeling complex, was found implicated in leukemia development and progression by regulating expression of cancer-related genes; thus, targeting BRD9 is considered a promising therapeutic strategy for leukemia [142]. The gene discussed is BRD9; the disease is leukemia.